O
SGNT

OppenheimerFunds’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

OppenheimerFunds’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,130
Closed -$152K – 1786
2016
Q2 		$152K Sell
10,130
-183
-2% -$2.35K ﹤0.01% 1648
2016
Q1 		$126K Sell
10,313
-199
-2% -$2.79K ﹤0.01% 1641
2015
Q4 		$167K Buy
+10,512
New +$165K ﹤0.01% 1688

OppenheimerFunds's SGNT Position: Q3 2016 in Review

OppenheimerFunds sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 10,130 shares — an estimated $152K sold.

OppenheimerFunds first reported a position in SGNT in Q4 2015 and held it in 3 quarters. The position peaked at $167K in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • OppenheimerFunds reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • OppenheimerFunds sold 10,130 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $152K.
  • OppenheimerFunds first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • OppenheimerFunds's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $167K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.